Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: Cases series and review of the literature

Hideaki Obara, Kentaro Matsubara, Naoki Fujimura, Yasuhito Sekimoto, Yuukou Kitagawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Only few studies have addressed the surgical revascularization in patients with both connective tissue disease (CTD) and critical limb ischemia (CLI), and the evidence for the endovascular treatment (EVT) is lacking in such patients. The main purpose of this study is to assess our outcome of EVT in patients with CTD and ischemic leg ulcers and review the current situation of the revascularization in such patients. Medical records of 10 consecutive patients with coexistent CTD and CLI-related leg ulcers (in 11 limbs) treated endovascularly at our institution between 2009 and 2013 were reviewed retrospectively. The patients had rheumatoid arthritis (n=5), systemic lupus erythematosus (n=1), progressive systemic scleroderma (n=3), or polyarteritis nodosa (n=1). EVT was technically successful in all the cases. No procedure-related morbidity or mortality occurred. During the mean follow-up period of 26 months, there were no major amputations, and sustained clinical improvement (ulcer healing and reduction in Rutherford category) was observed in eight limbs. The overall 1-year rates of amputation-free survival and freedom from reintervention were 89 and 81%, respectively. In our series of patients with CTD and ischemic leg ulcers, EVT had acceptable outcomes and may be recommended as a safe and reasonably effective initial treatment option for such patients.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalInternational Journal of Angiology
Volume24
Issue number2
DOIs
Publication statusPublished - 2014 Dec 12

Fingerprint

Connective Tissue Diseases
Ischemia
Extremities
Leg Ulcer
Therapeutics
Amputation
Diffuse Scleroderma
Polyarteritis Nodosa
Systemic Scleroderma
Systemic Lupus Erythematosus
Ulcer
Medical Records
Rheumatoid Arthritis
Morbidity
Survival
Mortality

Keywords

  • connective tissue disease
  • critical limb ischemia
  • endovascular treatment
  • rheumatoid arthritis
  • scleroderma

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{b84de9fadbcc49aeaebfd599d98a11a3,
title = "Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: Cases series and review of the literature",
abstract = "Only few studies have addressed the surgical revascularization in patients with both connective tissue disease (CTD) and critical limb ischemia (CLI), and the evidence for the endovascular treatment (EVT) is lacking in such patients. The main purpose of this study is to assess our outcome of EVT in patients with CTD and ischemic leg ulcers and review the current situation of the revascularization in such patients. Medical records of 10 consecutive patients with coexistent CTD and CLI-related leg ulcers (in 11 limbs) treated endovascularly at our institution between 2009 and 2013 were reviewed retrospectively. The patients had rheumatoid arthritis (n=5), systemic lupus erythematosus (n=1), progressive systemic scleroderma (n=3), or polyarteritis nodosa (n=1). EVT was technically successful in all the cases. No procedure-related morbidity or mortality occurred. During the mean follow-up period of 26 months, there were no major amputations, and sustained clinical improvement (ulcer healing and reduction in Rutherford category) was observed in eight limbs. The overall 1-year rates of amputation-free survival and freedom from reintervention were 89 and 81{\%}, respectively. In our series of patients with CTD and ischemic leg ulcers, EVT had acceptable outcomes and may be recommended as a safe and reasonably effective initial treatment option for such patients.",
keywords = "connective tissue disease, critical limb ischemia, endovascular treatment, rheumatoid arthritis, scleroderma",
author = "Hideaki Obara and Kentaro Matsubara and Naoki Fujimura and Yasuhito Sekimoto and Yuukou Kitagawa",
year = "2014",
month = "12",
day = "12",
doi = "10.1055/s-0035-1547516",
language = "English",
volume = "24",
pages = "137--142",
journal = "International Journal of Angiology",
issn = "1061-1711",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease

T2 - Cases series and review of the literature

AU - Obara, Hideaki

AU - Matsubara, Kentaro

AU - Fujimura, Naoki

AU - Sekimoto, Yasuhito

AU - Kitagawa, Yuukou

PY - 2014/12/12

Y1 - 2014/12/12

N2 - Only few studies have addressed the surgical revascularization in patients with both connective tissue disease (CTD) and critical limb ischemia (CLI), and the evidence for the endovascular treatment (EVT) is lacking in such patients. The main purpose of this study is to assess our outcome of EVT in patients with CTD and ischemic leg ulcers and review the current situation of the revascularization in such patients. Medical records of 10 consecutive patients with coexistent CTD and CLI-related leg ulcers (in 11 limbs) treated endovascularly at our institution between 2009 and 2013 were reviewed retrospectively. The patients had rheumatoid arthritis (n=5), systemic lupus erythematosus (n=1), progressive systemic scleroderma (n=3), or polyarteritis nodosa (n=1). EVT was technically successful in all the cases. No procedure-related morbidity or mortality occurred. During the mean follow-up period of 26 months, there were no major amputations, and sustained clinical improvement (ulcer healing and reduction in Rutherford category) was observed in eight limbs. The overall 1-year rates of amputation-free survival and freedom from reintervention were 89 and 81%, respectively. In our series of patients with CTD and ischemic leg ulcers, EVT had acceptable outcomes and may be recommended as a safe and reasonably effective initial treatment option for such patients.

AB - Only few studies have addressed the surgical revascularization in patients with both connective tissue disease (CTD) and critical limb ischemia (CLI), and the evidence for the endovascular treatment (EVT) is lacking in such patients. The main purpose of this study is to assess our outcome of EVT in patients with CTD and ischemic leg ulcers and review the current situation of the revascularization in such patients. Medical records of 10 consecutive patients with coexistent CTD and CLI-related leg ulcers (in 11 limbs) treated endovascularly at our institution between 2009 and 2013 were reviewed retrospectively. The patients had rheumatoid arthritis (n=5), systemic lupus erythematosus (n=1), progressive systemic scleroderma (n=3), or polyarteritis nodosa (n=1). EVT was technically successful in all the cases. No procedure-related morbidity or mortality occurred. During the mean follow-up period of 26 months, there were no major amputations, and sustained clinical improvement (ulcer healing and reduction in Rutherford category) was observed in eight limbs. The overall 1-year rates of amputation-free survival and freedom from reintervention were 89 and 81%, respectively. In our series of patients with CTD and ischemic leg ulcers, EVT had acceptable outcomes and may be recommended as a safe and reasonably effective initial treatment option for such patients.

KW - connective tissue disease

KW - critical limb ischemia

KW - endovascular treatment

KW - rheumatoid arthritis

KW - scleroderma

UR - http://www.scopus.com/inward/record.url?scp=84930383541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930383541&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1547516

DO - 10.1055/s-0035-1547516

M3 - Article

AN - SCOPUS:84930383541

VL - 24

SP - 137

EP - 142

JO - International Journal of Angiology

JF - International Journal of Angiology

SN - 1061-1711

IS - 2

ER -